<div class="panel-group" role="tablist" id="refPanel">
	<div class="panel panel-default">
		<div class="panel-heading">
			<h4 class="panel-title">
				<a role="button" data-toggle="collapse" data-parent="#refPanel" href="#refCollapse" id="refTitle">
					<span class="glyphicon glyphicon-collapse-down" aria-hidden="true" style="font-size: 80%;"></span>
					Additional Selected Readings
				</a>
			</h4>
		</div>
		<div id="refCollapse" class="panel-collapse collapse">
			<div class="panel-body">
				<ol>
					<li> Almirall, D., Compton, S. N., Gunlicks-Stoessel, M., Duan, N. and Murphy, S. A. (2012), &quot;Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy,&quot;<I> Statistics in medicine </I>, 31, 1887-1902.
					<li> Auyeung, S. F., Long, Q., Royster, E. B., Murthy, S., McNutt, M. D., Lawson, D., Miller, A., Manatunga, A. and Musselman, D. L. (2009), &quot;Sequential multiple-assignment randomized trial design of neurobehavioral treatment for patients with metastatic malignant melanoma undergoing high-dose interferon-alpha therapy,&quot;<I> Clinical trials (London, England) </I>, 6, 480-490. 
					<li> Bembom, O. and van der Laan, Mark J. (2008), &quot;Analyzing sequentially randomized trials based on causal effect models for realistic individualized treatment rules,&quot;<I> Statistics in medicine </I>, 27, 3689-3716.
					<li> Bembom, O. and van der Laan, M. J. (2007), &quot;Statistical methods for analyzing sequentially randomized trials,&quot;<I> Journal of the National Cancer Institute </I>, 99, 1577-1582. 
					<li> Buyze, J. and Goetghebeur, E. (2013), &quot;Evaluating dynamic treatment strategies: does it have to be more costly?&quot;<I> Pharmaceutical statistics </I>, 12, 35-42.
					<li> Buyze, J., Van Rompaye, B. and Goetghebeur, E. (2010), &quot;Designing a sequentially randomized study with adherence enhancing interventions for diabetes patients,&quot;<I> Statistics in medicine </I>, 29, 1114-1126.
					<li> Chakraborty, B. and Murphy, S. A. (2014), &quot;Dynamic treatment regimes,&quot;<I> Annual Review of Statistics and its Application </I>, 1, 447-464.
					<li> Chakraborty, B. (2011), &quot;Dynamic Treatment Regimes for Managing Chronic Health Conditions: A Statistical Perspective,&quot; <I> Am J Public Health </I>, 101, 40-45.
					<li> Cohen, J. (2013), <I> Statistical Power Analysis for the Behavioral Sciences,</I> 2nd ed., Hillsdale, NJ: Lawrence Erlbaum Associates, Inc.
					<li> Dawson, R. and Lavori, P. W. (2004), &quot;Placebo-free designs for evaluating new mental health treatments: the use of adaptive treatment strategies,&quot;<I> Statistics in medicine </I>, 23, 3249-3262.
					<li> Dawson, R. and Lavori, P. W. (2010), &quot;Sample size calculations for evaluating treatment policies in multi-stage designs,&quot;<I> Clinical trials (London, England) </I>, 7, 643-652.
					<li> Feng, W. and Wahed, A. S. (2009), &quot;Sample size for two-stage studies with maintenance therapy,&quot;<I> Statistics in medicine </I>, 28, 2028-2041.
					<li> Feng, W. and Wahed, A. S. (2008), &quot;Supremum weighted log-rank test and sample size for comparing two-stage adaptive treatment strategies, &quot;<I> Biometrika </I>, 95, 695-707.
					<li> Goldberg, Y. and Kosorok, M. R. (2012), &quot;Q-Learning with Censored Data,&quot;<I> Annals of statistics </I>, 40, 529-560.
					<li> Guo, X. and Tsiatis, A. (2005), &quot;A weighted risk set estimator for survival distributions in two-stage randomization designs with censored
					survival data,&quot;<I> The International Journal of Biostatistics </I>, 1, 1-15.
					<li> Hern&#225;n, M. A., Lanoy, E., Costagliola, D. and Robins, J. M. (2006), &quot;Comparison of dynamic treatment regimes via inverse probability 
					weighting,&quot;<I> Basic &amp; clinical pharmacology &amp; toxicology </I>, 98, 237-242.
					<li> Kidwell, K. M. and Wahed, A. S. (2013), &quot;Weighted log-rank statistic to compare shared-path adaptive treatment strategies,&quot;
					<I> Biostatistics (Oxford, England) </I>, 14, 299-312.
					<li> Ko, J. H. and Wahed, A. S. (2012), &quot;Up-front versus sequential randomizations for inference on adaptive treatment strategies,&quot;
					<I> Statistics in medicine </I>, 31, 812-830.
					<li> Lavori, P. W., Dawson, R. and Rush, A. J. (2000), &quot;Flexible treatment strategies in chronic disease: clinical and research implications,
					&quot;<I> Biological psychiatry </I>, 48, 605-614.
					<li> Lavori, P. W. and Dawson, R. (2008), &quot;Adaptive treatment strategies in chronic disease,&quot;<I> Annual Review of Medicine </I>, 59, 443-453.
					<li> Lavori, P. W. and Dawson, R. (2004), &quot;Dynamic treatment regimes: practical design considerations,&quot;<I> Clinical trials 
					(London, England) </I>, 1, 9-20.
					<li> Lei, H., Nahum-Shani, I., Lynch, K., Oslin, D. and Murphy, S. A. (2012), &quot;A &quot;SMART&quot; design for building individualized treatment 
					sequences,&quot;<I> Annual review of clinical psychology </I>, 8, 21-48.
					<li> Li, Z. and Murphy, S. A. (2011), &quot;Sample size formulae for two-stage randomized trials with survival outcomes,&quot;<I> Biometrika </I>, 98, 503-518.
					<li> Li, Z., Valenstein, M., Pfeiffer, P. and Ganoczy, D. (2014), &quot;A global logrank test for adaptive treatment strategies based on observational studies,
					&quot;<I> Statistics in medicine </I>, 33, 760-771.
					<li> Lokhnygina, Y. and Helterbrand, J. D. (2007), &quot;Cox Regression Methods for Two-Stage Randomization Designs,&quot;<I> Biometrics </I>, 63, 422-428.
					<li> Lunceford, J. K., Davidian, M. and Tsiatis, A. A. (2002), &quot;Estimation of Survival Distributions of Treatment Policies in Two-Stage Randomization Designs
					in Clinical Trials,&quot;<I> Biometrics </I>, 58, 48-57.
					<li> Miyahara, S. and Wahed, A. S. (2010), &quot;Weighted Kaplan-Meier estimators for two-stage treatment regimes,&quot; <I> Statistics in medicine </I>, 29, 2581-2591.
					<li> Moodie, E. E., Richardson, T. S. and Stephens, D. A. (2007), &quot;Demystifying optimal dynamic treatment regimes,&quot;<I> Biometrics </I>, 63, 447-455.
					<li> Murphy, S. A., Lynch, K. G., Oslin, D., McKay, J. R. and TenHave, T. (2007), &quot;Developing adaptive treatment strategies in substance abuse research,&quot;
					<I> Drug and alcohol dependence </I>, 88, S24-S30.
					<li> Murphy, S. A., Oslin, D. W., Rush, A. J. and Zhu, J. (2007), &quot;Methodological challenges in constructing effective treatment sequences for chronic 
					psychiatric disorders,&quot;<I> Neuropsychopharmacology </I>, 32, 257-262.
					<li> Nahum-Shani, I., Qian, M., Almirall, D., Pelham, W. E., Gnagy, B., Fabiano, G. A., Waxmonsky, J. G., Yu, J. and Murphy, S. A. (2012), &quot;Experimental design
					and primary data analysis methods for comparing adaptive interventions.&quot;<I> Psychological methods </I>, 17, 457.
					<li> Nahum-Shani, I., Qian, M., Almirall, D., Pelham, W. E., Gnagy, B., Fabiano, G. A., Waxmonsky, J. G., Yu, J. and Murphy, S. A. (2012), &quot;Q-learning: A data
					analysis method for constructing adaptive interventions.&quot;<I> Psychological methods </I>, 17, 478.
					<li> Oetting, A., Levy, J., Weiss, R. and Murphy, S. (2007)<I>, &quot;Statistical methodology for a SMART design in the development of adaptive treatment strategies,
					&quot;</I><I> in <I>Causality and Psychopathology: Finding the Determinants of Disorders and their Cures (American Psychopathological Association)</I></I>, 
					Arlington, VA: American Psychiatric Publishing, Inc., pp. 179-205.
					<li> Orellana, L., Rotnitzky, A. and Robins, J. M. (2010), &quot;Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, 
					part I: main content,&quot;<I> The International Journal of Biostatistics </I>, 6.
					<li> Robins, J. (1986), &quot;A new approach to causal inference in mortality studies with a sustained exposure period-application to control of the healthy worker 
					survivor effect,&quot;<I> Mathematical Modelling </I>, 7, 1393-1512.
					<li> Robins, J. M. (1997)<I>, &quot;Causal inference from complex longitudinal data,&quot;</I><I> in Latent variable modeling and applications to causality</I>, 
					New York: Springer, pp. 69-117.
					<li> Tang, X. and Wahed, A. S. (2011), &quot;Comparison of treatment regimes with adjustment for auxiliary variables,&quot;<I> Journal of Applied Statistics </I>,
					38, 2925-2938.
					<li> Thall, P. F. (2008), &quot;A review of phase 2-3 clinical trial designs,&quot;<I> Lifetime Data Analysis </I>, 14, 37-53.
					<li> Thall, P. F., Millikan, R. E. and Sung, H. (2000), &quot;Evaluating multiple treatment courses in clinical trials,&quot;<I> Statistics in medicine </I>, 19, 1011-1028.
					<li> Thall, P. F., Wooten, L. H., Logothetis, C. J., Millikan, R. E. and Tannir, N. M. (2007), &quot;Bayesian and frequentist two-stage treatment strategies based on
					sequential failure times subject to interval censoring,&quot;<I> Statistics in medicine </I>, 26, 4687-4702.
					<li> Thall, P. F., Logothetis, C., Pagliaro, L. C., Wen, S., Brown, M. A., Williams, D. and Millikan, R. E. (2007), &quot;Adaptive therapy for androgen-independent prostate
					cancer: a randomized selection trial of four regimens,&quot;<I> Journal of the National Cancer Institute </I>, 99, 1613-1622.
					<li> Wahed, A. S. and Thall, P. F. (2013), &quot;Evaluating joint effects of induction-salvage treatment regimes on overall survival in acute leukaemia,&quot;<I> Journal of 
					the Royal Statistical Society: Series C (Applied Statistics) </I>, 62, 67-83.
					<li> Wahed, A. S. and Tsiatis, A. A. (2006), &quot;Semiparametric efficient estimation of survival distributions in two-stage randomisation designs in clinical trials with 
					censored data,&quot;<I> Biometrika </I>, 93, 163-177.
					<li> Wahed, A. S. and Tsiatis, A. A. (2004), &quot;Optimal Estimator for the Survival Distribution and Related Quantities for Treatment Policies in Two-Stage Randomization 
					Designs in Clinical Trials,&quot;<I> Biometrics </I>, 60, 124-133.
					<li> Wang, L., Rotnitzky, A., Lin, X., Millikan, R. E. and Thall, P. F. (2012), &quot;Evaluation of viable dynamic treatment regimes in a sequentially randomized trial of
					advanced prostate cancer,&quot;<I> Journal of the American Statistical Association </I>, 107, 493-508.
					<li> Wolbers, M. and Helterbrand, J. D. (2008), &quot;Two-stage randomization designs in drug development,&quot;<I> Statistics in medicine </I>, 27, 4161-4174.
					<li> Zhao, Y., Zeng, D., Rush, A. J. and Kosorok, M. R. (2012), &quot;Estimating individualized treatment rules using outcome weighted learning,&quot;<I> Journal
					of the American Statistical Association </I>, 107, 1106-1118.
					<li> Zhao, Y., Zeng, D., Socinski, M. A. and Kosorok, M. R. (2011), &quot;Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer,
					&quot;<I> Biometrics </I>, 67, 1422-1433.
				</ol>
			</div>
		</div>
	</div>
</div>

<script>
	$(document).ready(function(){
		$('#refCollapse').on('hide.bs.collapse', function(){
			$('#refTitle').html('<span class="glyphicon glyphicon-collapse-down" style="font-size: 80%;"></span> Additional Selected Readings');
		});
		$('#refCollapse').on('show.bs.collapse', function(){
			$('#refTitle').html('<span class="glyphicon glyphicon-collapse-up" style="font-size: 80%;"></span> Additional Selected Readings');
		});
	});
</script>
	